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Abstract
Background: Stem cells with the ability to form clonal floating colonies (spheres) were recently
isolated from the neonatal murine spiral ganglion. To further examine the features of inner ear-
derived neural stem cells and their derivatives, we investigated the effects of leukemia inhibitory
factor (LIF), a neurokine that has been shown to promote self-renewal of other neural stem cells
and to affect neural and glial cell differentiation.
Results: LIF-treatment led to a dose-dependent increase of the number of neurons and glial cells
in cultures of sphere-derived cells. Based on the detection of developmental and progenitor cell
markers that are maintained in LIF-treated cultures and the increase of cycling nestin-positive
progenitors, we propose that LIF maintains a pool of neural progenitor cells. We further provide
evidence that LIF increases the number of nestin-positive progenitor cells directly in a cell cycle-
independent fashion, which we interpret as an acceleration of neurogenesis in sphere-derived
progenitors. This effect is further enhanced by an anti-apoptotic action of LIF. Finally, LIF and the
neurotrophins BDNF and NT3 additively promote survival of stem cell-derived neurons.
Conclusion: Our results implicate LIF as a powerful tool to control neural differentiation and
maintenance of stem cell-derived murine spiral ganglion neuron precursors. This finding could be
relevant in cell replacement studies with animal models featuring spiral ganglion neuron
degeneration. The additive effect of the combination of LIF and BDNF/NT3 on stem cell-derived
neuronal survival is similar to their effect on primary spiral ganglion neurons, which puts forward
spiral ganglion-derived neurospheres as an in vitro model system to study aspects of auditory
neuron development.
Background
Sphere-forming stem cells of the inner ear, characterized
by their ability to self-renew and to differentiate into mul-
tiple cell types, can be isolated from vestibular sensory
epithelia as well as from the cochlear organ of Corti and
the spiral ganglion [1-10]. Spiral ganglion-derived spheres
have been first isolated from the adult guinea pig and
human inner ear [3] and, more recently, from murine
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inner ear tissue [7,8]. These spheres consist of a mixed
population of a few bona fide stem cells, neural progenitor
cells, and differentiating cell types; they can be distin-
guished from sensory epithelia-derived spheres by their
ease of dissociation and by their grape cluster-like mor-
phology [3,7,8]. Inner ear-derived stem cells have been
put forward as a potential source of replacement cells for
sensory hair cell and auditory neuron degeneration,
which are the leading causes of hearing impairment,
affecting more than 250 million people worldwide [11-
13].
LIF is well known for promoting self-renewal of murine
embryonic [14] as well as murine and human neural stem
cells [15,16]. It binds to a heterodimeric membrane recep-
tor complex consisting of LIF receptor (LIFR, also
described as LIFR-beta) and glycoprotein 130 (gp130),
which leads to the activation of the Janus kinase – signal
transducer and activator of transcription (Jak-STAT) path-
way [17,18]. Other known cytokines signaling via the
same principal pathway are ciliary neurotrophic factor,
interleukin-6, interleukin-11, oncostatinM, cardio-
trophin-1, and cardiotrophin-like cytokine [19]. The
effects of LIF and related cytokines on distinct progenitor
cell populations in development and in response to injury
are promiscuous. They range from modulation of neuro-
genesis [20], to control of glial responses to injury [21],
and to affecting neural progenitors in vitro [15,16] and in
vivo [22,23]. In the inner ear, LIF has been shown to pro-
mote the survival of spiral ganglion neurons in culture,
acting synergistically with the neurotrophins BDNF and
NT3 [24,25].
In this study, we investigated whether treatment with LIF
increases the self-renewal capacity of spiral ganglion stem
cells. We found that treatment with LIF affected the adher-
ence properties of spiral ganglion spheres, making it
impossible to propagate spiral ganglion stem cells as
spheres. However, we encountered a strong dose-depend-
ent effect of LIF on neural cell differentiation. This effect is
based on several mechanisms including increased prolif-
eration and decreased apoptosis of neural progenitors,
but most prominently by a direct promotion of neural dif-
ferentiation. Overall, our results show that LIF and neuro-
trophins strongly promote neurogenesis of progenitors
derived from spiral ganglion stem cells, and that LIF alone
is capable of maintaining a pool of cycling neural progen-
itors derived from spiral ganglion stem cells.
Results
LIF treatment causes floating spiral ganglion-derived 
spheres to adhere and inhibits primary sphere formation
We set out to test whether LIF affects self-renewal of spiral
ganglion stem cells by culturing spheres in the presence of
LIF. Within 45 minutes after addition of LIF to floating
spheres, all spheres started to attach to the plastic bottoms
of the suspension culture dishes used for maintenance of
floating spheres. After 3 hours, 100% of the spheres were
attached at all concentrations tested (from 0.1 – 10 ng, n
= 10). Spheres did not attach when we added 0.002% BSA
(vehicle control) or other unrelated recombinant factors
(BDNF or NT3) from the same supplier. This effect made
it unfeasible to culture and to propagate spheres in the
presence of LIF, which made it impossible to determine
potential effects of LIF on the self-renewal of spiral gan-
glion-derived sphere-forming stem cells under non-adher-
ent conditions. Furthermore, we noted that adding LIF at
a concentration of 10 ng/ml completely inhibited forma-
tion of primary spheres from dissociated spiral ganglion
cells. These effects of LIF are not without precedent as it
has been reported that LIF impairs the formation of neu-
rospheres from embryonic brain-derived neural stem cells
and that it leads to attachment of neurospheres [26].
Increase of TuJ- and GFAP-positive cells in LIF-treated 
sphere-derived cultures
To investigate a potential effect of LIF on sphere-derived
adherent cell populations, we cultured the attached cells
from 30 spheres for each experiment in differentiation
medium (defined in the Methods section below) in the
presence or absence of LIF. After 10 days, we determined
the total number of cells, the number of TuJ-positive cells
with neural morphology, and the number of cells express-
ing the glial marker GFAP. We noticed that the total cell
number did not significantly change when we compared
cultures treated with different concentrations of LIF to
control cultures (Fig. 1A). The number of TuJ-positive
cells, however, was significantly increased in a dose-
dependent manner reaching a maximum at 1 ng/ml LIF,
with no further increase even with a 10x higher concentra-
tion of LIF (Fig. 1B–E). Only a few GFAP-positive cells
were detectable in sphere-derived cell populations cul-
tured in the absence of LIF, but with increasing LIF con-
centration, we observed higher numbers of GFAP-
expressing cells. The number of GFAP-positive cells was
significantly increased when compared with controls at
0.7 ng/ml and 1 ng/ml LIF (Fig. 1B). To verify that the
neurons and glial cell types differentiated during the 10-
day culture period, we analyzed sphere cell populations 3
hours after attachment and did not detect TuJ- or GFAP-
positive cells (data not shown), demonstrating that at the
onset of the experiment, spheres do not contain differen-
tiated neurons and glial cells.
LIF maintains neural progenitor cells in sphere-derived 
cultures
Using RT-PCR, we analyzed the expression of mRNA
encoding the receptor components of the LIF signaling
pathway and found that LIFR and gp130 were robustly
expressed in spheres and also in sphere-derived cell popu-BMC Developmental Biology 2007, 7:112 http://www.biomedcentral.com/1471-213X/7/112
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lations cultured for 10 days in differentiation medium in
the presence of 10 ng/ml LIF (Fig. 2A). Both genes were
expressed weaker in cultures that were not treated with
LIF. LIFR and gp130 were also detectable in spiral ganglia,
validating the previously reported effects of LIF on spiral
ganglion neuron survival [24,25]. LIF mRNA expression
was detectable in spiral ganglia and robustly in spheres
(Fig. 2B). After 10 days culture of sphere-derived cells
without LIF addition, we did not detect LIF expression;
when LIF protein was added, however, LIF mRNA was
unambiguously detectable.
Otx2 is a transcription factor that appears to have multiple
roles in inner ear development including a proposed
involvement in the specification of the spiral ganglion
[27-29]. We detected Otx2 mRNA in the neonatal spiral
ganglion, as well as in spiral ganglion-derived spheres
(Fig. 2A). Interestingly, LIF-treatment led to robust main-
tenance of this developmentally important transcription
factor, whereas Otx2 expression was not detectable in
untreated cultures. A similar expression profile was
observed for islet-1, a gene expressed in early auditory and
vestibular neurons [30]. The two neural progenitor mark-
ers nestin [31] and musashi-1 [32] were also robustly
expressed in the neonatal spiral ganglion and spiral gan-
glion-derived spheres and were maintained in sphere-
derived LIF-treated cultures (Fig. 2A). The general expres-
sion pattern observed with developmental and progenitor
cell genes suggests that LIF appears to sustain a pool of
inner ear neural progenitor cells in cultures derived from
spiral ganglion spheres. This pool of cells seems to lose
expression of developmental and precursor markers in the
absence of LIF. RT-PCR analysis also confirmed our
immunocytological results suggesting upregulation and/
or maintenance of the neural markers neurofilament-M,
peripherin, GluR2, GluR3, and GluR4 [33,34], as well as
the glial marker GFAP in LIF-treated sphere-derived cul-
tures (Fig. 2A).
LIF treatment leads to an increase of TuJ and GFAP positive cells without affecting the total cell number Figure 1
LIF treatment leads to an increase of TuJ and GFAP positive cells without affecting the total cell number. (A): The total cell 
number of sphere-derived cells after 10 days in culture did not significantly change when treated with different concentrations 
of LIF. n = 4. (B): The percentage of TuJ-positive cells was significantly increased in a dose-dependent manner up-to 7-fold. 
Likewise, the percentage of GFAP-expressing cells was increased in response to LIF. The percent values express the fraction of 
immunopositive cells of the total cell number. Error bars indicate S.E.M. * indicates p < 0.05, ** indicates p < 0.01, n = 6. (C-E): 
Representative images of differentiated cells of non-LIF-treated cultures (C), and cultures treated with 0.1 ng/ml (D) and 10 ng/
ml LIF (E). Scale bar = 200 µm.BMC Developmental Biology 2007, 7:112 http://www.biomedcentral.com/1471-213X/7/112
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Expression of NGF, BDNF, and NT-3 was strong in spiral
ganglia (Fig. 2B). BDNF appeared to be expressed at rela-
tive high levels in spheres and after LIF-treatment, whereas
the other two neurotrophins were maintained at lower
levels, compared with BDNF expression. Expression of
TrkA mRNA was not detectable in any of the cell popula-
tions analyzed, whereas TrkB was robustly expressed in
spiral ganglia and spheres, and moderately in sphere-
derived cultures. TrkC was detectable in spiral ganglia,
absent in spheres, detectable at low levels in non-LIF-
treated cultures, and appeared to be upregulated in
response to LIF. The low-affinity neurotrophin receptor
p75NTR was expressed in spiral ganglia and in sphere-
derived cell cultures treated with LIF.
Increased BrdU incorporation and increased number of 
neural progenitor cells in LIF-treated cultures
To further elucidate the mechanism(s) by which LIF
affects spiral ganglion stem cell-derived progenitor popu-
lations, we determined whether LIF modulates the
number of proliferating cells. In the first 48 hours of cul-
turing attached spheres in differentiation medium in the
presence of LIF, we found that the number of cells that
incorporated the thymidine analog BrdU was significantly
increased by 64% (Fig. 3A). Furthermore, LIF-treatment
led to a twofold increase of nestin-positive cells as well as
a doubling of the BrdU and nestin double-positive cell
population (Fig. 3A–C). This experiment revealed two dif-
ferent effects of LIF. First, LIF appears to promote cell pro-
liferation of nestin-negative as well as of nestin-positive
cells, which in part explains the overall increase of nestin-
positive cells. Nevertheless, the 64% increase of total
BrdU-positive cells cannot completely account for the
stark expansion of the nestin-positive cell population.
Consequently, we propose a second effect of LIF, which is
induction of nestin expression in nestin-negative sphere-
derived cells.
LIF promotes differentiation of neural progenitors
We hypothesized that LIF could also be directly affecting
neural differentiation of progenitor cells, thereby, decreas-
ing the mitotic potency of neural progenitors. As BrdU
showed detrimental effects when we cultured spiral gan-
glion sphere-derived cells for longer than 4 days, we used
an alternative method for tracing proliferating cells. Three
hours after attachment, sphere-derived cells were loaded
with carboxy fluorescein diacetate succinimidyl ester
(CFSE) and then cultured for 12 days in differentiation
medium in the presence or absence of LIF. Mitotic cell
divisions distribute the fluorescent CFSE compound
between the daughter cells, which results in a decrease of
the fluorescence intensity with each round of cell division.
Analysis of CFSE fluorescence intensity after 12 days
revealed that the majority of TuJ- and GFAP-positive cells
in LIF-treated cultures retained the CFSE label at higher
levels than in untreated cultures (Fig. 4A–D,G–J). This
result indicates that the neurons and glial cells in LIF-
treated cultures arose from progenitors that underwent
fewer mitotic division cycles than those in untreated cul-
tures, which suggests that LIF directly induced neural and
glial cell differentiation. Together with the observation
that LIF directly promotes the generation of nestin-posi-
tive cells (Fig. 3A), we conclude that LIF has the ability to
accelerate differentiation of neural progenitors.
We also analyzed the distribution of CFSE in TuJ- and
GFAP-negative cells and found that LIF affected these cells
in an opposite manner, manifesting in a lower concentra-
tion of retained CFSE label when compared with
untreated controls (Fig. 4E,F). This result is in agreement
with our observation that the overall cell number does not
significantly change compared to untreated controls (Fig.
1A).
(A-B): RT-PCR analyses of marker gene expression in spiral  ganglion from P1 mouse (SG(P1), first column of lanes), spiral  ganglion-derived spheres (second column of lanes), differenti- ated spheres without LIF treatment after a 10-day culture  period (LIF(-), third column of lanes), and differentiated  spheres treated with 10 ng/ml of LIF after a 10-day culture  period (LIF(+), fourth column of lanes) Figure 2
(A-B): RT-PCR analyses of marker gene expression in spiral 
ganglion from P1 mouse (SG(P1), first column of lanes), spiral 
ganglion-derived spheres (second column of lanes), differenti-
ated spheres without LIF treatment after a 10-day culture 
period (LIF(-), third column of lanes), and differentiated 
spheres treated with 10 ng/ml of LIF after a 10-day culture 
period (LIF(+), fourth column of lanes). None of the two 
TrkA primer pairs employed in this study amplified TrkA 
cDNA from RNA preparations of spiral ganglia, spheres, or 
sphere-derived cells – one representative result is shown. 
Both primer pairs were successfully tested in control experi-
ments with mouse dorsal root ganglia and hindbrain cDNA 
as template (not shown).BMC Developmental Biology 2007, 7:112 http://www.biomedcentral.com/1471-213X/7/112
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LIF broadly promotes survival in sphere-derived cultures
An additional mechanism by which LIF could increase the
number of neural and glial cells in spiral ganglion stem
cell-derived cell populations is by promoting cell survival.
We used AnnexinV to detect phosphatidylserine, which is
redistributed in apoptotic cells from the internal to the
external plasma membrane leaflet [35]. In the first 48
hours of culturing attached spheres in differentiation
medium, we found that in the presence of LIF, the number
of apoptotic cells was significantly reduced (Fig. 5). The
number of nestin-positive apoptotic cells was equally
reduced, indicating that LIF appears to generally promote
cell survival in spiral ganglion sphere-derived cell popula-
tions.
LIF, BDNF, and NT3 act in concert to promote neural 
differentiation and survival
It has previously been reported that LIF and the neuro-
trophins BDNF and NT3 act synergistically in survival
assays of neonatal primary spiral ganglion neurons [24].
Although we did not observe a synergistic action on neu-
ron numbers in spiral ganglion sphere-derived cell popu-
lations, we found an additive effect (Fig. 6). Co-treatment
with LIF, BDNF, and NT3 led to the highest fraction of
neurons, up-to a maximum of 15% of the total cell num-
bers. NGF, as expected for inner ear-derived neural popu-
lations [36], was not effective. In combination with LIF,
however, NGF-treatment resulted in fewer TuJ-expressing
cells than in the appropriate controls indicating that NGF
may exert a negative effect on neurogenesis in these con-
ditions. Nevertheless, the observed effects of neuro-
trophins BDNF, NT3, and LIF on sphere-derived neuron
survival are very similar to the effects of these factors on
primary spiral ganglion neurons isolated from newborn
mice [25].
Discussion
Spiral ganglion-derived stem cells are promising candi-
dates for generating replacement auditory neurons, which
could be used in transplantation experiments with animal
models of auditory nerve degeneration [37,38]. In this
study, we focused on determining possible functions of
the cytokine LIF on progenitor cells that reside in spheres
generated from spiral ganglion stem cells. We found that
LIF strongly impairs the formation and propagation of
spiral ganglion-derived spheres. A qualitatively similar
effect of LIF has been reported on fetal neural stem cells
[26]. We consequently focused on the potential roles of
LIF on sphere-derived adherent cell populations, and
revealed several mechanisms by which LIF promotes the
formation of neurons and GFAP-positive glial cells.
Our results differ quantitatively from a previous study of
sphere-derived cells that were isolated from adult guinea
pigs [3]. In this previous study, most cells expressed glial
or neural markers, whereas we found that most sphere-
derived cells did neither express GFAP or TuJ. We hypoth-
esize that these distinctions could be due to differences in
Increased BrdU incorporation and increased number of neural progenitor cells in response to LIF treatment Figure 3
Increased BrdU incorporation and increased number of neural progenitor cells in response to LIF treatment. (A): Quantifica-
tion of BrdU-positive, nestin-positive, and BrdU/nestin-double positive cells 48 h after plating. Error bars indicate S.E.M., * indi-
cates p < 0.05, ** indicates p < 0.01, n = 8. Total cell numbers did not differ significantly when we compared LIF-treated with 
untreated cultures (1934 ± 403 and 2008 ± 435, respectively). (B-C): Representative pictures of plated sphere-derived cells 
without LIF treatment (B), and with 10 ng/ml LIF (C). Scale bar = 200 µm. (C'-C''): Higher magnification of two nestin-positive 
cells from (C) to illustrate the nuclear localization of the BrdU staining in one of the cells.BMC Developmental Biology 2007, 7:112 http://www.biomedcentral.com/1471-213X/7/112
Page 6 of 11
(page number not for citation purposes)
experimental design, which includes use of different spe-
cies, use of different immunological tools, different time
points of analyses, and different combinations of added
factors.
We demonstrate that LIF treatment in a dose-dependent
manner increases the number of neurons and glial cells
that differentiated in cultures of sphere-derived cells.
These neurons and glial cells were newly generated
because neither cell type was detectable when we analyzed
spheres directly after plating. By RT-PCR, we revealed that
developmental and progenitor cell markers are main-
tained in LIF-treated cultures, whereas their expression
was starkly reduced or absent in untreated cultures. These
results suggest that LIF has a function in maintaining neu-
ral progenitor cells in spiral ganglion sphere-derived cul-
tures.
LIF mRNA was detectable at relatively low levels in P1 spi-
ral ganglia, but was robustly found in spheres and was
maintained in sphere-derived cultures in the presence of
LIF. It is noteworthy that addition of LIF to spiral ganglion
cells inhibited sphere formation, but on the other hand,
LIF mRNA expression was detectable in spheres. This indi-
cates that LIF might indeed play a role in stem cell or pro-
genitor cell maintenance in spheres.
Analysis of cell divisions of TuJ and GFAP expressing cells, and TuJ and GFAP-negative cells in response to LIF Figure 4
Analysis of cell divisions of TuJ and GFAP expressing cells, and TuJ and GFAP-negative cells in response to LIF. (A-F): CFSE 
intensity distribution histograms comparing control cultures (no LIF) with LIF-treated cultures for TuJ-positive (A,B), GFAP-
positive (C,D), and TuJ & GFAP-negative (E,F) cells. The distribution shifts indicate that TuJ and GFAP-expressing cells retained 
more CFSE label in LIF-treated cultures when compared with untreated cultures. The TuJ & GFAP-negative cells retained less 
label, suggesting that these cells underwent more divisions in response to LIF. (G-H): CFSE signals (green) in TuJ-positive cells 
(red). Nuclei are shown in blue. (I-J): CFSE signals (green) in GFAP-positive cells (white). Nuclei are shown in blue. Arrow-
heads point to cells displaying well retained CFSE label and arrows indicate cells with less intense CFSE label. Scale bar = 100 
µm.BMC Developmental Biology 2007, 7:112 http://www.biomedcentral.com/1471-213X/7/112
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When we cultured sphere-derived cell populations, we
found that LIF-treatment resulted in an increase of cells
that incorporated BrdU. This growth-promoting effect was
detectable in both nestin-positive and nestin-negative
cells. Nestin-positive cells are neural progenitor cells, and
the effect of LIF on those cells may account for the main-
tenance of a pool of cycling nestin-expressing progenitors
in LIF-treated cultures. We further noted that the overall
fraction of nestin-positive cells was starkly increased in
response to LIF; this increase was disproportionately large
compared to the effect of LIF on proliferating nestin-posi-
tive progenitors. We consequently conclude that LIF
affected a population of nestin-negative progenitor cells
to develop into neural progenitors. Our results do not
directly address the question of whether these LIF-induced
nestin-positive cells are proliferating. Our CFSE label-
retention experiments suggest, however, that in the pres-
ence of LIF, many neural and glial precursors directly dif-
ferentiate into mature cell types whereas in untreated
cultures, the precursors proliferated more strongly.
In summary, we propose that LIF affects distinct popula-
tions of progenitor cells in spiral ganglion sphere-derived
cell populations in different manners. First, LIF promotes
the maintenance of cycling nestin-positive progenitor
cells. These cells may be the pool of stem cells that origi-
nally had the ability to form spheres; a hypothesis that
needs to be further tested. Second, LIF increases the
number of nestin-positive progenitor cells in a cell cycle-
independent fashion, probably by inducing neural pro-
genitor cell features in a population of nestin-negative
cells. Third, LIF accelerates neurogenesis in the majority of
neural progenitors by promoting their differentiation at
the cost of their proliferative potential. This proposed
third role of LIF somewhat contradicts the action of main-
taining circling progenitors. A possible explanation for
such an antidromic effect is the heterogeneity of sphere-
derived cell populations, where different sub pools of pro-
genitors appear to be affected in a different manner. We
hypothesize that all LIF actions are in agreement with a
general role in promoting neurogenesis and simultaneous
maintenance of a precursor cell pool, which puts this
cytokine forward as a powerful tool to control the fate of
spiral ganglion stem cell-derived progenitor populations
in vitro.
The multiple effects of LIF on spiral ganglion sphere-
derived cells became even more obvious when we com-
pared the number of apoptotic cells in treated and
untreated populations. Here, we noticed a general ability
of LIF to promote survival of both nestin-positive and nes-
tin-negative cells. Anti-apoptotic action of LIF has been
previously observed [39,40], and this effect seems to con-
tribute to the overall health and robust neurogenesis that
we observed in LIF-treated cultures of spiral ganglion
sphere-derived cells.
Simultaneous treatment with LIF and the neurotrophins
BDNF and NT3 resulted in an increased occurrence of
neurons when compared with cultures treated with each
factor alone. We interpret this additive effect as the result
Additive effects of LIF, BDNF, and NT-3 on neurogenesis Figure 6
Additive effects of LIF, BDNF, and NT-3 on neurogenesis. 
Quantification of the fraction of TuJ-expressing cells of the 
total number of cells treated with LIF and different combina-
tions of neurotrophins. The analysis was done after a 10-day 
differentiation period. LIF was used at 10 ng/ml, BDNF and 
NT-3 at 50 ng/ml, and NGF at 20 ng/ml. Error bars indicate 
S.E.M., * indicates p < 0.05, ** indicates p < 0.01, n = 3.
Reduction of apoptotic cells in LIF treated sphere-derived  cell cultures 48 h after plating Figure 5
Reduction of apoptotic cells in LIF treated sphere-derived 
cell cultures 48 h after plating. Annexin-positive cells and 
annexin & nestin-double positive cell populations were signif-
icantly decreased in response to LIF. Error bars indicate 
S.E.M., * indicates p < 0.05, ** indicates p < 0.01, n = 4. Total 
cell numbers did not differ significantly when we compared 
LIF-treated with untreated cultures (1124 ± 363 and 894 ± 
516, respectively).BMC Developmental Biology 2007, 7:112 http://www.biomedcentral.com/1471-213X/7/112
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of independent and overlapping neurogenic and trophic
mechanisms. These include the neurogenic actions of LIF
on progenitors, the trophic effects of LIF on sphere-
derived cells, as well as the neurotrophic effects of BDNF
and NT3 on neurons. Auditory and vestibular neurons
depend on BDNF and NT3, but not on NGF [36]. NGF
alone had no effect on the number of neurons generated
in sphere-derived cultures, but in conjunction with LIF,
we observed a decrease in the number of differentiated
neurons.
Neurotrophins act via binding to the high-affinity Trks
and the low-affinity neurotrophin receptor p75NTR. Only
TrkB and TrkC mRNAs were detectable in sphere-derived
cultures, which is in agreement with previous studies of
sphere-derived cell populations made from guinea pig
spiral ganglion [3]. TrkB and BDNF mRNAs were robustly
detectable in spheres, indicating that this signaling path-
way might be distinctly active in these cell populations,
when compared with the other two neurotrophins. We
did not detect TrkA mRNA in spiral ganglia, in spiral gan-
glia-derived spheres, and in sphere-derived cultures,
which is in agreement with the majority of previous stud-
ies ([41-44], but see [45]). We consequently hypothesize
that the reduction of the fraction of TuJ-positive cells in
response to NGF in LIF-treated cultures (Fig. 6) could be a
result of NGF action on p75NTR. Expression of the low-
affinity neurotrophin receptor p75NTR was indeed detecta-
ble in spiral ganglia and in sphere-derived cell popula-
tions after treatment with LIF (Fig. 2B). p75NTR interacts
with Trks resulting in enhancement of their ligand specif-
icity and affinity, thereby modulating Trk-mediated neu-
ronal survival (reviewed in [46]). Other studies have
revealed that activation of p75NTR can also mediate apop-
tosis in a Trk-independent fashion (reviewed in [47]). We
speculate that the negative effect of NGF on neurogenesis
in cultures that were simultaneously treated with LIF
could be the result of an apoptotic effect via p75NTR sign-
aling.
The expression of peripherin and glutamate receptor sub-
types in sphere-derived cells, particularly after LIF treat-
ment indicates that sphere-derived populations maintain
a distinct spiral ganglion neuron phenotype. Such main-
tenance of organ-specific cellular identity, a feature of
many somatic stem cell-derived cell populations, qualifies
spiral ganglion-derived sphere-forming stem cells as a
bona fide cell source for transplantation studies toward
replacement of lost peripheral auditory neurons.
Conclusion
We demonstrate that LIF is highly efficient in promoting
neurogenesis of spiral ganglion stem cell-derived cultures.
We propose that LIF treatment may be useful to expand
adherent spiral ganglion stem cell populations and, fur-
thermore, that such a treatment may enhance the number
of auditory neurons after transplantation of LIF-treated
spiral ganglion sphere-derived cells.
Methods
Isolation of spiral ganglion stem cells for sphere formation
Postnatal day 1 (P1) C57/BL6 mice were used for each
experiment. All procedures followed the approved institu-
tional protocol according to the National Institutes of
Health guidelines for animal care. The otic capsule was
isolated and dissected carefully from the surrounding tis-
sue. The capsule was then opened apically and removed
with forceps followed by dissecting away the spiral liga-
ment and stria vascularis. The organ of Corti was peeled
off from the modiolus, which harbors spiral ganglion cells
and neuronal fibers. The dissected spiral ganglia were
washed with ice-cold Hanks' media. Individual ganglia
were then transferred into 50 µl drops of PBS. 50 µl of
0.25% trypsin solution with EDTA (#25200-056, Invitro-
gen) was added and the tissue was incubated for 5 min-
utes at 37°C. The enzymatic reaction was blocked with
100  µl of a solution consisting of 10 mg/ml soybean
trypsin inhibitor (Worthington) and 1 mg/ml DNaseI
(Worthington) in DMEM/high-glucose and F12 media
(mixed 1:1). Gentle trituration was performed with plastic
pipette tips (epTIPS Filter 20–300 µl, Eppendorf). The cell
suspension was further diluted with 1.8 ml of DMEM/
high-glucose and F12 media (mixed 1:1, Invitrogen) sup-
plemented with N2 and B27 supplements, EGF (20 ng/
ml), bFGF (10 ng/ml), IGF-1 (50 ng/ml), and heparan sul-
phate (50 ng/ml) (all growth factors were obtained from
R&D Systems and Sigma). Larger tissue fragments and cel-
lular debris were removed by passing the cell suspension
through a 70 µm cell strainer directly into a 6-well cell sus-
pension culture plate (Greiner Bio-One). This procedure
generally yielded a completely dissociated single cell sus-
pension virtually devoid of aggregates. The cells were
incubated at 37°C for 7 days to allow for primary sphere
formation. Primary spheres were passaged after 7 days in
culture by a 7 minute treatment with Accumax (Innova-
tive Cell Technologies) at 37°C, followed by mild 5
minute centrifugation (150rcf). The supernatant was aspi-
rated leaving about 200 µl. Using a fire polished glass
pipette, the pellet was triturated and the resulting cell sus-
pension was resuspended in 1.8 ml of DMEM/high-glu-
cose and F12 media (mixed 1:1) supplemented with N2
and B27 supplements, EGF (20 ng/ml), bFGF (10 ng/ml),
IGF-1 (50 ng/ml), and heparan sulphate (50 ng/ml). We
microscopically ensured that a single cell suspension was
generated. This suspension was then incubated at 37°C
for 7 days to obtain second-generation spheres. We have
previously shown that this procedure is feasible for long-
term propagation of spiral ganglion-derived spheres [7,8].BMC Developmental Biology 2007, 7:112 http://www.biomedcentral.com/1471-213X/7/112
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Cell differentiation
To study cell differentiation, 30 equally sized second-gen-
eration spheres were transferred per experimental data
point into plastic 4-well tissue culture plates (Greiner 35/
10 mm 4-well tissue culture dishes) coated with 0.1% gel-
atin (Chemicon). Recombinant rat LIF (Chemicon,
#LIF3005) was added directly into the differentiation
medium consisting of DMEM/high-glucose and F12
media (mixed 1:1) supplemented with N2 at 37°C. 80%
of the medium was replaced every other day. The differen-
tiated cells were analyzed by immunocytochemistry after
10 days to assess the dose-dependent characteristics of
LIF-treatment. Cells were analyzed after 2 days to deter-
mine uptake of bromodeoxyuridine (BrdU) (B2506,
Sigma), as well as after 12 days to assess the retention of
carboxy fluorescein diacetate, succinimidyl ester (BrdU
and CFSE assays, see below). To ensure that all neurons
and glial cells were newly generated during the cell differ-
entiation period, we analyzed the population of cells
derived from spheres 4 hours after attaching and never
encountered any cells that expressed neuron-specific beta-
III tubulin (TuJ) or GFAP. The neurotrophins BDNF, NT-
3, and NGF (R&D Systems) were used in combination
with LIF in the experiments shown in Fig. 6.
Immunocytochemistry
For immunodetection, the cells were fixed with 4% para-
formaldehyde in phosphate-buffered saline (PBS, pH7.2)
for 15 min at room temperature. Nonspecific binding
sites were blocked for 1 hour in 0.1% Triton-100, 1% BSA
(wt/vol), and 5% (wt/vol) heat-inactivated goat serum in
PBS (PBT1). The fixed cells were incubated overnight at
4°C with diluted antibodies: 1:500 for monoclonal
mouse antibody IgG2a to neuron-specific beta-III tubulin
(TuJ, MMS-435P; Covance), 1:500 for polyclonal rabbit
antibody to GFAP (Dako), 1:500 for polyclonal rabbit
antibody to nestin (courtesy of Dr. Ronald McKay,
NINDS), and 1:500 for monoclonal mouse antibody to
BrdU (B2531, Sigma). Unbound antibodies were
removed by three PBT1 washes and one PBT2 (same as
PBT1 but without serum) wash for 15 min each at room
temperature. FITC-conjugated, TRITC-conjugated, and
Cy5-conjugated goat anti-rabbit and anti-mouse second-
ary antibodies (Jackson ImmunoResearch) were diluted
1:400 in PBS. A 2-hr incubation period in the secondary-
antibody mixture preceded three washes for 15 min each
in PBS. Counterstaining with short-wavelength nuclear
staining agent DAPI (Molecular Probes) was done to visu-
alize cell nuclei. The coverslipped slides were analyzed by
fluorescence microscopy and digital image acquisition
(Zeiss Axioimager and AxioCam).
BrdU assay
Equally sized second-generation spheres were plated into
gelatin-coated dishes as described above. One batch of
spheres was cultured with 5 µg/ml BrdU and 10 ng/ml of
LIF in DMEM/high-glucose and F12 media (mixed 1:1)
supplemented with N2. The second batch of spheres was
cultured with 5 µg/ml BrdU and 0.002% bovine serum
albumin (BSA, vehicle control) in the same culture
medium. After 48 hours, the differentiated cells were ana-
lyzed by immunocytochemistry for uptake of BrdU. This
experiment was repeated using 6 different mice, and was
compared with a baseline experiment, using the same
conditions but stopped after 4 hours.
CFSE fluorescence
To further assess cell proliferation, we employed carboxy-
fluorescein diacetate succinimidyl ester (CFSE, Invitrogen,
C-1157). CFSE enters the cells by passive diffusion. It is
colorless and non-fluorescent until intracellular esterases
remove acetate groups from it and convert it to anionic
CFSE that fluoresces. Anionic CFSE is well retained within
cells and is equally distributed to the daughter cells after
mitosis. CFSE labeling has been used as an alternative to
standard proliferation analysis techniques such as [3H]-
thymidine incorporation and BrdU labeling [48]. We used
this method because BrdU appeared to be toxic when used
for longer than 4 days in our sphere-derived cultures.
Spheres were transferred into gelatin-coated dishes and
allowed to attach for 3 hours. CFSE was then added to a
final concentration of 10 mM and after an incubation
period of 18 minutes at 37°C, unincorporated CFSE was
washed off with two rinses of PBS. Cells were then cul-
tured at 37°C in medium containing 10 ng/ml of LIF for
LIF-treated group and 0.002% BSA for the vehicle control
group. The differentiated cells were analyzed by immuno-
cytochemistry after 12 days to assess the retention of CFSE
in TuJ-positive and GFAP-positive cells in the LIF-treated
group compared to controls. Cy5- and TRITC-conjugated
antibodies were used to detect primary antibodies, and
DAPI was used to visualize nuclei. The FITC channel was
used to visualize CFSE fluorescence. For each experimen-
tal data point, we assessed five random areas of at least 30
cells. Settings on the microscope were standardized for
each analysis at a fixed gain and an exposure time set at
1500 ms for the FITC channel; background correction was
likewise standardized. ImageJ [49] was used for measur-
ing the intensity of CFSE in all TuJ-positive, GFAP-positive
cells, and in non-TuJ/non-GFAP-positive cells, and the
results were plotted as a histogram.
Apoptosis assay
Sphere-derived cells, cultured with LIF (10 ng/ml) or
without LIF, were analyzed after 48 hours. Recombinant
Annexin-V conjugated with FITC (ApoTarget™, Biosource
Internatioal, CA USA) was added to the cultures, incu-
bated for 15 minutes, and washed with PBS. The cells were
then fixed with 4% PFA and incubated overnight at 4°C
with diluted primary antibodies as described above. Cy5-BMC Developmental Biology 2007, 7:112 http://www.biomedcentral.com/1471-213X/7/112
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conjugated secondary antibodies were used to detect pri-
mary antibodies. DAPI was used to visualize nuclei.
Statistical analysis
We applied Student's t-test to matched-paired samples
and we considered results significant at p < 0.05.
RNA isolation and RT-PCR
Total RNA was isolated using RNeasy Mini kits (Qiagen).
Reverse transcription was performed with Superscript III
(Invitrogen). The resulting cDNAs were used as templates
in polymerase chain reactions using the following primer
pairs (forward, reverse, cDNA product length): Otx2 (5'-
CCATGACCTATACTCAGGCTTCAGG-3', 5'-GAAGCTC-
CATATCCCTGGGTGGAAAG-3', 211 bp), islet-1 (5'-CAC-
CTTGCGGACCTGGTATGCC-3', 5'-
GCTACCATGCTGTTGGGTGTATC-3', 450 bp), nestin (5'-
GCCGAGCTGGAGCGCGAGTTAGAG-3', 5'-GCAAG-
GGGGAAGAGAAGGATGTCG-3', 694 bp), musashi1 (5'-
ACCTACGCCAGCCGGAGTTACAC-3', 5'-
CTGGGGCGCTCCTGCTACCTC-3', 444 bp), neurofila-
ment-M (5'-GCACATCACGGTAGAGCGCAAAG-3', 5'-
TCGTGCGCGCACTGGAATGCG-3', 450 bp), peripherin
(5'-GTGAGCGTAGAGAGCCAGCAGG-3', 5'-
TCGAAGCTCTTCCTCCAGCCGT-3', 474 bp), GluR2 (5'-
TAAAATGTGGACTTATATGAGGAGTG-3', 5'-CTCTCGAT-
GCCATATACGTTGTAAC-3', 573 bp), GluR3 (5'-
GAAAATGTGGTCTTACATGAAATCCG-3', 5'-TGAGTGTT-
GGTGGCAGGAGCA-3', 525 bp), GluR4 (5'-ATGAGGAT-
TATTTGCAGGCAG-3', 5'-
TCAATGAAGGTCTTAGCTGAAG-3', 415 bp), GFAP (5'-
CCTCCGCCAAGCCAAACACGAA-3', 5'-ACCATCCCG-
CATCTCCACAGTC-3', 433 bp), LIFR (5'-CAACCAACAA-
CATGCGAGTG-3', 5'-GGTATTGCCGATGTGTCCTG-3',
680 bp), gp130 (5'-CCACATACGAAGACAGACCA-3', 5'-
GCGTTCTCTGACAACACACA-3', 433 bp), NGF (5'-
GAAGGAGACTCTGTCCCTGAAGC-3', 5'-TGATGTCTGT-
GGCTGTGGTCTTA-3', 376 bp), BDNF (5'-CGCAAACAT-
GTCTATGAGGGTTC-3', 5'-
TAGTAAGGGCCCGAACATACGAT-3', 302 bp), NT3 (5'-
TAGAACCTCACCACGGAGGAAAC-3', 5'-
AGGCACACACACAGGAAGTGTCT-3', 359 bp), TrkA(1)
(5'-GGTACCAGCTCTCCAACACTGAGG-3', 5'-CCA-
GAACGTCCAGGTAACTGGGTG-3', 204 bp), TrkA(2) (5'-
CAGGGACTAGTGGTGAAGATTGG-3', 5'-TAGCCCA-
GAACGTCCAGGTAAC-3', 413 bp), TrkB (5'-GTACT-
GAGCCTTCTCCAGGCATC-3', 5'-
CGTCAGGATCAGGTCAGACAAGT-3', 305 bp), TrkC (5'-
TACTACAGGGTGGGAGGACACAC-3', 5'-TTTAGGGCA-
GACTCTGGGTCTCT-3', 225 bp), p75NTR (5'-CCGAT-
GCTCCTATGGCTACTACC-3', 5'-
CTATGAGGTCTCGCTCTGGAGGT-3', 353 bp), LIF (5'-
CTTACTGCTGCTGGTTCTGCACT-3', 5'-GTAGCATT-
GAGCTTGACCTGGAG-3', 393 bp), GAPDH (5'-AACG-
GGAAGCCCATCACCATCTT-3', 5'-
CAGCCTTGGCAGCACCAGTGG-3', 442 bp). All RT-PCR
results presented were principally confirmed with at least
two independent control experiments.
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